3rd Quarter - Report

ACG ADVOCACY for LYNDRA THERAPEUTICS, INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$70,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 8, 2020 $70,000 Replaced
3rd Quarter - Termination Jan 14, 2021 $70,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues related to advanced pharmaceutical and domestic supply chain.

LobbyistCovered position, as disclosed
MARY O'DEA AHEARN ALLEN —
DAVID J URBAN Chief of Staff, Senator Arlen Specter

Contacted: Health & Human Services, Dept of (HHS); White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.